MammaPrint and BluePrint Molecular Diagnostics Using Targeted RNA Next-Generation Sequencing Technology-Reference-Cited by-同舟云学术

MammaPrint and BluePrint Molecular Diagnostics Using Targeted RNA Next-Generation Sequencing Technology

Published:2019-09 Issue:5 Volume:21 Page:808-823
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Mittempergher Lorenza,Delahaye Leonie J.M.J.,Witteveen Anke T.,Spangler Jacob B.,Hassenmahomed Fariet,Mee Sammy,Mahmoudi Soufiane,Chen Jiang,Bao Simon,Snel Mireille H.J.,Leidelmeijer Sandra,Besseling Naomi,Bergstrom Lucas Anne,Pabón-Peña Carlos,Linn Sabine C.,Dreezen Christa,Wehkamp Diederik,Chan Bob Y.^ORCID,Bernards René,van 't Veer Laura J.,Glas Annuska M.

Funder

European Union Seventh Framework Programme

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference49 articles.

1. Advanced applications of RNA sequencing and challenges;Han;Bioinform Biol Insights,2015

2. Translating RNA sequencing into clinical diagnostics: opportunities and challenges;Byron;Nat Rev Genet,2016

3. Gene expression profiling predicts clinical outcome of breast cancer;van't Veer;Nature,2002

4. A gene-expression signature as a predictor of survival in breast cancer;van de Vijver;N Engl J Med,2002

5. A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study;Drukker;Int J Cancer,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted DNA-seq and RNA-seq of Reference Samples with Short-read and Long-read Sequencing;Scientific Data;2024-08-16

2. Clinical Biomarkers of Tumour Radiosensitivity and Predicting Benefit from Radiotherapy: A Systematic Review;Cancers;2024-05-20

3. Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade;npj Breast Cancer;2024-04-18

4. Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) Trial;JCO Precision Oncology;2024-02

5. Quartet RNA reference materials improve the quality of transcriptomic data through ratio-based profiling;Nature Biotechnology;2023-09-07